Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Second chance for AstraZeneca’s selumetinib with breakthrough designation

Second chance for AstraZeneca’s selumetinib with breakthrough designation

AstraZeneca has also just paid out a hefty $1.35bn upfront payment to become partners with Daiichi Sankyo on its late-stage antibody drug conjugate for HER2+ breast cancer.

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug Filing due later this year. AstraZeneca has made a big bet on a HER2-targeted antibody-drug conjugate developed by Daiichi Sankyo as it tries to add another pillar to its ... Daiichi Sankyo has said that means its drug can carry a greater cytotoxic

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain The challenge for Daiichi Sankyo with mirogabalin will be positioning it as a realistic alternative to pregabalin when Lyrica generics hit the market. ... Like the original Lyrica formulation Daiichi Sankyo’s drug is dosed twice-daily.

Astellas, Catalyst approvals set up record year for FDA approvals

Astellas, Catalyst approvals set up record year for FDA approvals Others are however moving through the late-stage pipeline, including Daiichi Sankyo’s quizartinib and Arog Pharma’s crenolanib.

The Healthcare Partnership is launched

The Healthcare Partnership is launched The company is headed by founder Duane Lacey (pictured), who has over 20 years’ experience within the industry having served in various roles for companies including AstraZeneca, Daiichi-Sankyo and Alliance

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics